David T. Coleman

1.0k total citations
21 papers, 767 citations indexed

About

David T. Coleman is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, David T. Coleman has authored 21 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Cancer Research. Recurrent topics in David T. Coleman's work include Contact Dermatitis and Allergies (3 papers), Tea Polyphenols and Effects (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). David T. Coleman is often cited by papers focused on Contact Dermatitis and Allergies (3 papers), Tea Polyphenols and Effects (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). David T. Coleman collaborates with scholars based in United States, Australia and South Korea. David T. Coleman's co-authors include James A. Cardelli, Rebecca L. Bigelow, Joshua J. Steffan, Cosby A. Stone, Christine Rukasin, Elizabeth J. Phillips, Jason A. Trubiano, Jennifer L. Carroll, C. A. L. Stephens and Briana J. Williams and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

David T. Coleman

20 papers receiving 760 citations

Peers

David T. Coleman
Glenn S. Van Aller United States
John Breton United States
Lei Hu China
İlker Dıbırdık United States
Bihua Lin China
Shrawan K. Mishra United States
Glenn S. Van Aller United States
David T. Coleman
Citations per year, relative to David T. Coleman David T. Coleman (= 1×) peers Glenn S. Van Aller

Countries citing papers authored by David T. Coleman

Since Specialization
Citations

This map shows the geographic impact of David T. Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Coleman more than expected).

Fields of papers citing papers by David T. Coleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David T. Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Coleman. The network helps show where David T. Coleman may publish in the future.

Co-authorship network of co-authors of David T. Coleman

This figure shows the co-authorship network connecting the top 25 collaborators of David T. Coleman. A scholar is included among the top collaborators of David T. Coleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David T. Coleman. David T. Coleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Atluri, Vidya, et al.. (2022). Safety of cefazolin for perioperative prophylaxis in patients with penicillin allergy labels. Annals of Allergy Asthma & Immunology. 129(1). 115–117. 6 indexed citations
3.
Stone, Cosby A., Shailesh K. Choudhary, Christine Rukasin, et al.. (2019). Tolerance of porcine pancreatic enzymes despite positive skin testing in alpha-gal allergy. The Journal of Allergy and Clinical Immunology In Practice. 8(5). 1728–1732.e1. 14 indexed citations
4.
Stone, Cosby A., Jason A. Trubiano, David T. Coleman, Christine Rukasin, & Elizabeth J. Phillips. (2019). The challenge of de‐labeling penicillin allergy. Allergy. 75(2). 273–288. 151 indexed citations
5.
Coleman, David T., et al.. (2018). Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes. Virology. 519. 1–11. 31 indexed citations
6.
Coleman, David T., et al.. (2016). Palmitoylation regulates the intracellular trafficking and stability of c-Met. Oncotarget. 7(22). 32664–32677. 30 indexed citations
7.
Coleman, David T., et al.. (2016). Monocarboxylate transporter 1 contributes to growth factor-induced tumor cell migration independent of transporter activity. Oncotarget. 7(22). 32695–32706. 22 indexed citations
8.
Coleman, David T., et al.. (2016). Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation. Oncotarget. 7(22). 32200–32209. 24 indexed citations
9.
Coleman, David T., Young Hwa Soung, Young‐Joon Surh, James A. Cardelli, & Jun Chung. (2015). Curcumin Prevents Palmitoylation of Integrin β4 in Breast Cancer Cells. PLoS ONE. 10(5). e0125399–e0125399. 42 indexed citations
10.
Mathis, J. Michael, et al.. (2015). Characterization of an oncolytic adenovirus vector constructed to target the cMet receptor. PubMed. 4. 119–119. 5 indexed citations
11.
Coleman, David T., et al.. (2015). Isothiocyanatostilbenes as novel c-Met inhibitors. Oncotarget. 6(38). 41180–41193. 2 indexed citations
13.
Steffan, Joshua J., Samantha S. Dykes, David T. Coleman, et al.. (2014). Supporting a Role for the GTPase Rab7 in Prostate Cancer Progression. PLoS ONE. 9(2). e87882–e87882. 57 indexed citations
14.
Coleman, David T. & James A. Cardelli. (2013). Abstract A83: c-Met requires palmitoylation for proper stability and trafficking in cancer cells. Cancer Research. 73(3_Supplement). A83–A83. 1 indexed citations
15.
Coleman, David T. & James A. Cardelli. (2012). Abstract 1216: c-Met protein expression is regulated by palmitoylation in prostate cancer cells. Cancer Research. 72(8_Supplement). 1216–1216. 1 indexed citations
16.
Coleman, David T., James A. Cardelli, & Joshua J. Steffan. (2011). The HGF-Met Signaling Axis: Emerging Themes and Targets of Inhibition. Current Protein and Peptide Science. 12(1). 12–22. 21 indexed citations
17.
Bigelow, Rebecca L., David T. Coleman, Joshua J. Steffan, et al.. (2010). The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells. Molecular Carcinogenesis. 49(8). n/a–n/a. 71 indexed citations
18.
Coleman, David T., Rebecca L. Bigelow, & James A. Cardelli. (2009). Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradation. Molecular Cancer Therapeutics. 8(1). 214–224. 58 indexed citations
19.
Milligan, Shawn A., Patrick Burke, David T. Coleman, et al.. (2009). The Green Tea Polyphenol EGCG Potentiates the Antiproliferative Activity of c-Met and Epidermal Growth Factor Receptor Inhibitors in Non–small Cell Lung Cancer Cells. Clinical Cancer Research. 15(15). 4885–4894. 96 indexed citations
20.
Chaturvedi, Sudha, Huilin Qi, David T. Coleman, et al.. (1999). Constitutive Calcium-independent Release of Toxoplasma gondii Dense Granules Occurs through the NSF/SNAP/SNARE/Rab Machinery. Journal of Biological Chemistry. 274(4). 2424–2431. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026